| Antidepressant-like activity and modulation of brain monoaminergic transmission by blockade of anandamide hydrolysis G Gobbi, FR Bambico, R Mangieri, M Bortolato, P Campolongo, M Solinas, ... Proceedings of the National Academy of Sciences 102 (51), 18620-18625, 2005 | 665 | 2005 |
| Antidepressant-like activity and modulation of brain monoaminergic transmission by blockade of anandamide hydrolysis G Gobbi, FR Bambico, R Mangieri, M Bortolato, P Campolongo, M Solinas, ... Proceedings of the National Academy of Sciences 102 (51), 18620-18625, 2005 | 665 | 2005 |
| Antidepressant-like activity and modulation of brain monoaminergic transmission by blockade of anandamide hydrolysis G Gobbi, FR Bambico, R Mangieri, M Bortolato, P Campolongo, M Solinas, ... Proceedings of the National Academy of Sciences 102 (51), 18620-18625, 2005 | 665 | 2005 |
| Aberrant insulin signaling in Alzheimer's disease: current knowledge G Bedse, F Di Domenico, G Serviddio, T Cassano Frontiers in neuroscience 9, 204, 2015 | 211 | 2015 |
| Anti-dyskinetic effects of cannabinoids in a rat model of Parkinson's disease: role of CB1 and TRPV1 receptors MG Morgese, T Cassano, V Cuomo, A Giuffrida Experimental neurology 208 (1), 110-119, 2007 | 172 | 2007 |
| Characterization and evaluation of chitosan nanoparticles for dopamine brain delivery A Trapani, E De Giglio, D Cafagna, N Denora, G Agrimi, T Cassano, ... International journal of pharmaceutics 419 (1-2), 296-307, 2011 | 170 | 2011 |
| Nonmotor symptoms in Parkinson's disease: Investigating early‐phase onset of behavioral dysfunction in the 6‐hydroxydopamine‐lesioned rat model I Branchi, I D'Andrea, M Armida, T Cassano, A Pezzola, RL Potenza, ... Journal of neuroscience research 86 (9), 2050-2061, 2008 | 123 | 2008 |
| Nonmotor symptoms in Parkinson's disease: Investigating early‐phase onset of behavioral dysfunction in the 6‐hydroxydopamine‐lesioned rat model I Branchi, I D'Andrea, M Armida, T Cassano, A Pezzola, RL Potenza, ... Journal of neuroscience research 86 (9), 2050-2061, 2008 | 123 | 2008 |
| The fat-induced satiety factor oleoylethanolamide suppresses feeding through central release of oxytocin S Gaetani, J Fu, T Cassano, P Dipasquale, A Romano, L Righetti, ... Journal of Neuroscience 30 (24), 8096-8101, 2010 | 112 | 2010 |
| Genetic deletion of fatty acid amide hydrolase alters emotional behavior and serotonergic transmission in the dorsal raphe, prefrontal cortex, and hippocampus FR Bambico, T Cassano, S Dominguez-Lopez, N Katz, CD Walker, ... Neuropsychopharmacology 35 (10), 2083-2100, 2010 | 108 | 2010 |
| Inhibition of fatty-acid amide hydrolase and CB1 receptor antagonism differentially affect behavioural responses in normal and PCP-treated rats A Seillier, T Advani, T Cassano, JG Hensler, A Giuffrida International journal of neuropsychopharmacology 13 (3), 373-386, 2010 | 101 | 2010 |
| Prenatal exposure to the CB1 receptor agonist WIN 55,212-2 causes learning disruption associated with impaired cortical NMDA receptor function and emotional reactivity changes … T Antonelli, MC Tomasini, M Tattoli, T Cassano, S Tanganelli, S Finetti, ... Cerebral cortex 15 (12), 2013-2020, 2005 | 101 | 2005 |
| Effects of perinatal exposure to delta-9-tetrahydrocannabinol on the emotional reactivity of the offspring: a longitudinal behavioral study in Wistar rats V Trezza, P Campolongo, T Cassano, T Macheda, P Dipasquale, ... Psychopharmacology 198 (4), 529-537, 2008 | 100 | 2008 |
| Glutamatergic alterations and mitochondrial impairment in a murine model of Alzheimer disease T Cassano, G Serviddio, S Gaetani, A Romano, P Dipasquale, S Cianci, ... Neurobiology of aging 33 (6), 1121. e1-1121. e12, 2012 | 95 | 2012 |
| Biochemical and neurobehavioral profile of CHF2819, a novel, orally active acetylcholinesterase inhibitor for Alzheimer's disease L Trabace, T Cassano, L Steardo, C Pietra, G Villetti, KM Kendrick, ... Journal of Pharmacology and Experimental Therapeutics 294 (1), 187-194, 2000 | 87 | 2000 |
| The endocannabinoid system as a target for novel anxiolytic and antidepressant drugs S Gaetani, P Dipasquale, A Romano, L Righetti, T Cassano, D Piomelli, ... International review of neurobiology 85, 57-72, 2009 | 84 | 2009 |
| Cannabinoid receptor 2 signaling in neurodegenerative disorders: from pathogenesis to a promising therapeutic target T Cassano, S Calcagnini, L Pace, F De Marco, A Romano, S Gaetani Frontiers in neuroscience 11, 30, 2017 | 83 | 2017 |
| Data available on the extent of cocaine use and dependence: biochemistry, pharmacologic effects and global burden of disease of cocaine abusers C Pomara, T Cassano, S D'Errico, S Bello, AD Romano, I Riezzo, ... Current medicinal chemistry 19 (33), 5647-5657, 2012 | 77 | 2012 |
| PRECLINICAL STUDY: Perinatal exposure to delta‐9‐tetrahydrocannabinol causes enduring cognitive deficits associated with alteration of cortical gene expression and … P Campolongo, V Trezza, T Cassano, S Gaetani, MG Morgese, M Ubaldi, ... Addiction biology 12 (3‐4), 485-495, 2007 | 75 | 2007 |
| The role of endocannabinoid signaling in the molecular mechanisms of neurodegeneration in Alzheimer's disease G Bedse, A Romano, AM Lavecchia, T Cassano, S Gaetani Journal of Alzheimer's Disease 43 (4), 1115-1136, 2015 | 73 | 2015 |
